Masu bincike na kasar Japan sun kirkiro wani magani wanda zai iya magance mura a cikin awanni 24

mura

Ba tare da wata shakka ba, duk 'yan adam suna da matsala babba a tare da shi. cutar mura, cutar da zata iya haifar da babbar illa ga dukkan al'ummomi. Tabbacin abin da na fada shi ne, alal misali, a Spain, ƙasar da abin ya shafa ƙwarai a cikin 'yan makonnin nan, musamman a yankuna kamar Aragon, La Rioja, Navarra, Catalonia da Basque Country a cikin' yan makonnin nan, koyaushe suna halartar masu bugawa Rahoton kwanan nan ta Surungiyar Kula da Cututtuka na idemasa.

Wannan ya faru ne saboda wata hanya ta musamman da ake kirkirar allurar rigakafin mura a kowace shekara. A matsayin cikakken bayani, gaya muku cewa, tunda ba zai yuwu a jira abin ya shafa ba don samar da allurar rigakafi, a zahiri abin da aka yi shi ne yin nazarin ko wane iri ne zai iya kamuwa da mu kuma daga nan ne za a ci gaba da rigakafin shekara mai zuwa. Wannan a ƙarshe ana fassara shi zuwa wani nau'in wasa na bazata, idan masu binciken sunyi gaskiya, alurar tana da fa'ida sosai, amma tana iya faruwa kamar wannan shekarar inda tasirin maganin ya sauka daga kashi 40-60% zuwa 25%.

kwaya

Me yasa ake kirkirar allurar rigakafi daga shekara guda zuwa shekara mai zuwa kuma ba koyaushe ake yin ta ba?

Duk lokacin da mutane suke magana game da irin wannan kwayar cutar, gaskiyar ita ce wannan tambayar ta taso, me yasa ba a samar da allurar rigakafin mura da ke da cikakken tasiri ba? Wannan, ba tare da wata shakka ba, zai zama manufa, da rashin alheri kwayar cutar mura tana da karfin maye gurbi wanda ke sa kwayar cutar ta canza sosai daga shekara guda zuwa ta gaba cewa allurar rigakafin ba za ta iya shafar ta ba.

A gefe guda, abin da yake gaskiya kuma mafi ban mamaki game da wannan aikin gabaɗaya shi ne, duk da cewa kowace shekara dole ne mu yi aiki don neman rigakafin, yawancin masu bincike sun sadaukar da duk ƙoƙarinsu don ƙirƙirar magani wanda zai iya warkar da wannan ilimin. . Bincike marasa awanni na bincike wanda, a cewar wata takarda da aka buga daga Japan, ga alama na iya zuwa ƙarshen tun lokacin da ƙungiyar masu bincike daga ƙasar suka sami nasarar haɓaka maganin da zai iya warkar da ku daga cutar cikin awanni 24 kawai.

kwayoyin

Japan ta fara amincewa da amfani da wani magani wanda yayi alkawarin warkar da mura a cikin awanni 24 kacal

Wannan sabon maganin kamfanin ne ya kirkireshi Shionogi tare da haɗin gwiwar ƙasashen Switzerland Roche. Shi kansa an yi masa baftisma da sunan Baloxavir marboxil Kuma ba wani abu bane, aƙalla na wannan lokacin, fiye da gwajin gwaji wanda amfanin sa na iya zama mai matuƙar tasiri wajen magance duka nau'in A da nau'in B. A matsayin cikakken bayani, gaya muku cewa wannan magani, sabanin sauran magungunan da suke wanzuwa kasuwa, kwaya ce kawai wacce za'a gudanar sau daya da baki.

Kamar yadda bayani ya bayyana Daniel O'Day, Daraktan Sashen Magunguna na Roche:

Baloxavir marboxil magani ne mai amfani sau ɗaya idan aka kwatanta shi da magani na kwana da yawa, wanda zai iya samar da wasu fa'idodi don shirin cutar. Ba ku da matsala ta yuwuwar juriya wanda zai iya bayyana idan ba ku kammala maganin ba.

Don samun irin wannan sakamakon, kamar yadda aka yi bayani, wannan magani yana toshe furotin da ƙwayar ke buƙata ta kwafa a cikin ƙwayoyin maharan. A ƙarshe kawai gaya muku hakan Shionogi ya riga ya kammala gwajin na uku na asibiti don tantance ingancin akwatin marlo na Baloxavir ta hanyar kwatanta amfani da shi da na placebo da sauran hanyoyin. Sakamakon binciken ya kammala da cewa marasa lafiyar da suka karɓi Baloxavir marboxil sun ɗauki kaɗan 24 a matsakaita don murmurewa a kan awanni 42 da ya ɗauka don marasa lafiya da aka ba da wuribo. Wadannan sakamakon sun sa Gwamnatin Japan ta amince da farko amfani da wannan maganin gwaji.


Bar tsokaci

Your email address ba za a buga. Bukata filayen suna alama da *

*

*

  1. Wanda ke da alhakin bayanan: Miguel Ángel Gatón
  2. Manufar bayanan: Sarrafa SPAM, sarrafa sharhi.
  3. Halacci: Yarda da yarda
  4. Sadarwar bayanan: Ba za a sanar da wasu bayanan ga wasu kamfanoni ba sai ta hanyar wajibcin doka.
  5. Ajiye bayanai: Bayanin yanar gizo wanda Occentus Networks (EU) suka dauki nauyi
  6. Hakkoki: A kowane lokaci zaka iyakance, dawo da share bayanan ka.